MERCK CANADA INC.
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Communicate with BC government about conditions under which innovative drugs and vaccines are marketed and reimbursed in BC, including under the BC Drug Plans or under federal legislation. In particular, communicating to emphasize the importance that federal and provincial governments respect their respective jurisdiction for approval of marketing and reimbursement of drugs.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Communicate with BC government to leverage BC programs and related resources/tools as a best practice in other markets.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Communicate with BC government to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs and vaccines.
|
Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Health
|
|
Discuss legislation enacted or proposed to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents.
|
Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
Health
|
|
Engage BC government on Merck’s commercial product/asset pipeline and seek access listing agreements.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Health
|